Cat. #152585
Anti-CD22 [RFB-4]
Cat. #: 152585
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: CD22
Class: Recombinant
Application: FACS ; IHC ; IF
Reactivity: Human
Host: Mouse
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: D Campana
Institute: Absolute Antibody ; University College London (UCL)
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CD22 [RFB-4]
- Clone: rRFB-4
- Tool sub type: Primary antibody
- Class: Recombinant
- Conjugation: Unconjugated
- Molecular weight: 153 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IF
- Description: Establishing origin of B cell malignancies, especially discriminating between immature (bone marrow type) and peripheral B cell leukaemias and lymphomas. Suitable for use as an immunotoxin against human B cell leukaemias and lymphomas.
- Immunogen: Tonsil lymphocytes
- Isotype: IgG1
Target Details
- Target: CD22
- Molecular weight: 153 kDa
- Target background: Establishing origin of B cell malignancies, especially discriminating between immature (bone marrow type) and peripheral B cell leukaemias and lymphomas. Suitable for use as an immunotoxin against human B cell leukaemias and lymphomas.
Applications
- Application: FACS ; IHC ; IF
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS only
- Storage conditions: -20° C
- Shipping conditions: Shipping at 4° C
Related Tools
- Related tools: Anti-CD22 [RFB-4]
References
- Bofill et al. 1985. J Immunol. 134(3):1531-8. PMID: 3871452.
- Human B cell development. II. Subpopulations in the human fetus.
